HIV treatment cascade in regions of Peru with the highest HIV prevalence.

Objectives: To describe the HIV treatment cascade and care continuum in regions of highest HIV prevalence in Peru.

Methods: An observational longitudinal study was carried out in 14 tertiary hospitals in Peru. These are the main hospitals that administer antiretroviral treatment (ART) in the regions that represent approximately 95% of reports of HIV/AIDS cases in Peru in 2013.

Transmitted resistance in HIV-1 of patients from nine departments of Peru.

The main aim of this research is to identify the transmitted resistance (RT) of the Human Immunodeficiency Virus (HIV) in subjects from nine cities of Peru. For this, a descriptive and cross-sectional study was carried out in 135 adult subjects who agreed to participate through an informed consent. Blood samples were collected to perform the CD4 / CD8 cell count, viral load and HIV Genotyping.

[Continuum of care of people living with HIV and gaps in achieving the 90-90-90 goals in Peru].

In 2013, the Joint United Nations Programme on HIV/AIDS (UNAIDS) proposed, in terms of public health, to end the HIV epidemic by 2030 by achieving the so-called 90-90-90 targets by 2020. This goal will only be possible if coverage in the HIV care continuum indicators is increased. With the methodology proposed by PAHO/WHO, this paper estimates the indicators of the continuum of care in Peru for 2014, consisting of diagnostic coverage, antiretroviral treatment (ART), and viral suppression in people living with HIV (PLHIV).

[Prevention of Maternal-Child Transmission of HIV in Pregnant Women and Mothers of the Awajun and Wampis Communities in the Amazon Region of Peru].

Objectives: To identify the barriers that limit compliance with the prevention of mother-to-child transmission (PMTCT) of HIV measures in two indigenous communities of the Amazon region of Peru.

Materials And Methods: Qualitative study with a phenomenological approach. Semi-structured interviews were conducted with pregnant women and mothers of children younger than 1 year of the awajún and wampis indigenous communities diagnosed with HIV in the period 2014-2015.

[Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus coinfection in Peru, 2010-2015].

Objective: Identify the programmatic barriers that hinder access to comprehensive care of patients with tuberculosis and human immunodeficiency virus (TB/HIV) coinfection.

Methods: This is a mixed-method study. Qualitative research was conducted via in-depth interviews with key actors and the quantitative component involved cross-sectional descriptive analysis of programmatic data from 2010-2015 on tuberculosis and HIV programs at health facilities in the cities of Lima and Iquitos.

[Antiretroviral therapy containing raltegravir in HIV-infected pregnant women: Systematic review].

Introduction: The risk of mother to child transmission (MTCT) of HIV increases in pregnant women diagnosed late in pregnancy. Some experts suggest that the use of raltegravir (RAL), as part of the antiretroviral treatment in these pregnant women, could reduce the risk of MTCT, since RAL can quickly decrease the viral load.

Objective: To evaluate the available scientific information on the efficacy and safety of RAL, during the third trimester of pregnancy, in reducing MTCT of HIV.

[Barriers to implementing screening, brief intervention and referral to treatment for substance use in HIV/AIDS health services in Peru].

Objectives.: Screening and treatment for substance use among people living with HIV/AIDS (PLWHA) is highly recommended. Nevertheless, in Peru healthcare for PLWHA does not include a standardized or systematic assessment to identify substance use.

[Cutaneous larva migrans after a trip to the Caribean].

Cutaneous larva migrans is a parasitic disease caused by Ancylostoma braziliense and Ancylostoma caninum larvae, which is transmitted by contact with sand infested with these parasites. Dogs and cats are the definitive hosts. This parasitic disease is endemic in the Caribbean, Africa, Australia, and Asia.

[Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].

Vaccination is one of the most important public health interventions in the reduction childhood morbidity and mortality. Thimerosal is an organic mercury compound used as preservante in multi-dose vials. Often in Peru, there are waves of controversy about the safety of this type of vaccines, mainly arguing that there is an association between them and autism.